Royalty Report: Medical, Device, Surgical – Collection: 257711


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 8


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 8

Primary Industries

  • Medical
  • Device
  • Surgical
  • Delivery
  • Personal Care Products

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 257711

License Grant
The Licensee has a License Agreement for the IP related to the its thoracostomy kit,  the  Thoraguide from the Inventors, two individuals.
License Property
The Thoracostomy kit involves the insertion of a thin plastic tube into the space between the lungs and the chest wall. The tube may be attached to a suction device to remove excess fluid or air.
Field of Use
A thoracostomy is a small incision of the chest wall, with maintenance of the opening for drainage. It is most commonly used for the treatment of a pneumothorax. This is performed by physicians, emergency response nurses, and paramedics, usually via needle thoracostomy, or with a thoracostomy tube (chest tube).

A pneumothorax is a collapsed lung. A pneumothorax occurs when air leaks into the space between your lung and chest wall. This air pushes on the outside of your lung and makes it collapse. Pneumothorax can be a complete lung collapse or a collapse of only a portion of the lung.

The Licensee develops new disposable medical devices.

IPSCIO Record ID: 214175

License Grant
The Company entered into an agreement to acquire the rights to manufacture and sell the KatGuide chest tube insertion tool.
License Property
KatGuide chest tube insertion tool is a tool that helps the doctors place chest drains.  KatGuide has an innovative design that promotes safe and accurate insertion and placement of large bore chest drains. It gently guides the drain in to the precise spot needed without perforating the lung.
Field of Use
This agreement pertains to the medical industry.

IPSCIO Record ID: 257713

License Grant
The Licensee entered into a License Agreement for the dual channel suction wand, RBS-2. The RBS-2 was invented by the Licensor, an individual, for use in the medical field.
License Property
The Dual channel suction wand, RBS-2 –  will directly shed blood or other liquids in more than one direction. Such a device was constructed of disposable plastic with a suction head with a standard tip that leads to a handle equipped with a clearly marked color-coded “thumb switch.” allowing the suctioned fluid to be directed into a double-barrel tubing system leading in two separate directions.
Field of Use
This agreement pertains to the medical device industry.

IPSCIO Record ID: 209561

License Grant
The Inventor, an individual, hereby sells, transfers, assigns, conveys, sets over, grants and delivers to Buyer, the Existing Technology and all of the Inventors worldwide rights, title and interest in and to the Existing Technology for whatever purpose or purposes Buyer shall, in its sole discretion, determine, including, without limitation, the exclusive right to make, use, or sell products utilizing the Existing Technology, and also including any and all prototypes, components, patents, patent infringement claims, trademarks and trade-names relating to the Existing Technology, all to the end that Buyer, by virtue of such purchase, shall be the sole owner of the Existing Technology.
License Property
Inventor has designed, invented and produced an experimental model of a nitinol blood clot filter.

'Patent' means that U.S. patent #4,425,908—— nitinol blood clot filter (the 'Filter').

Field of Use
The agreement is for the medical industry.

IPSCIO Record ID: 1850

License Grant
The Company entered into an agreement for the license for Epidural catheters used to infuse drugs into the epidural space in the spinal column (vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system (vii) Intra-aortic balloon catheters (viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.
Field of Use
Fields of Application)
(v) Epidural catheters used to infuse drugs into the epidural space in the spinal column.
(vi) Implantable infusion ports and pumps and their attached catheters used for drug therapy and access to the vascular system.
(vii) Intra-aortic balloon catheters.
(viii) Drainage catheters used to drain chest cavities, surgical incisions, wounds and abscesses.

IPSCIO Record ID: 165371

License Grant
The parties agree to an agreement that includes an exclusive option period for 90 days to evaluate the system and to enter into a License Agreement prior to the conclusion of the option period.  The Licensee will receive an Exclusive worldwide marketing and sales rights to the System utilizing Licensor Ultrasonic Liposuction technology (including Patent No. 5,419,761; and all improvement patents and foreign patents now or hereafter held by Licensor).  Licensor retains the rights to ultrasonic technologies for non-medical applications.
License Property
The System is referred to as a ultrasonic technology, and prototype manufacturing capabilities to design and assemble one or more ultrasonic systems specifically for use in performing the Procedure.

The Procedure is referred to as Liposuction or Liposculpturing which are medical devices specifically designed to improve the treatment of patients desiring a surgical procedure.

Patent No. 5,419,761  Liposuction apparatus and associated method

Field of Use
This agreement pertains to the medical industry relating especially to the specialties of Plastic and Reconstructive Surgery, Cosmetic Surgery and Surgical Dermatology.

IPSCIO Record ID: 4411

License Grant
The assignment of the intellectual property agreement for International Patent Application No. PCT/IB2010/000797 to Licensee, the Hong Kong affiliate.
License Property
PCT/IB2010/000797 A Device and Method for Lifting Abdominal Wall During Medical Procedure

IPSCIO Record ID: 28316

License Grant
The parties now wish to enter into a new exclusive license agreement, as hereinafter set forth, whereby Licensor is to grant to Licensees the exclusive license within the Territories to market and sell the System now and hereafter produced by Licensor, during the term of this Agreement, solely for uses in body sculpting, liposuction, or lipscuplturing, and for no other use, and Licensee desires to enter into the Agreement and to assign its rights thereunder to Lysonix, while remaining fully liable for performance and payment of all obligations thereunder on the part of Lysonix.
License Property
Licensee to Receive Exclusive marketing and sales rights to the System in the Territories utilizing Ultrasonic Liposuction technology and know-how (including but not limited to Patent No. 5,419,761; and all improvement patents and patent applications and foreign patents relating to ultrasonic equipment) which pertain to the Procedure, however, Licensor retains the rights to exploitation of the System and its ultrasonic technologies for all other applications, medical and non-medical, other than body sculpting, liposuction and lipsculpturing.

Patent No. 5,419,761 – relating to ultrasonic equipment

Field of Use
This agreement pertains to the medical industry.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.